Cancro del Seno e MDB (Pubblicazioni Scientifiche)

Pubblicato il 10/01/2024

Pubblicazioni sui Tumori al Seno del Metodo Di Bella
Reperibili su ResearchGate, Pubmed e sul Sito ufficiale del Metodo Di Bella

 Observational retrospective clinical study on the application of the Di Bella Method (DBM) from 2004 to today on breast carcinomas. Preliminary data on survival improvement, objective responseand performance status Giuseppe Di Bella, Vittoria Borghetto, Elena Costanzo, Ilaria Moscato. November 2021. Conference: NZBCS-2021: THE VIRTUAL NZ BREAST CANCER SYMPOSIUM At: Nuova Zelanda
(testo in italiano)

 Bella GD, Colori B, Scanferlato R (2018) The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer. Transl Biomed. Vol.9 No.1:146
(testo in italiano)

 Bella GD, Scanferlato R, Colori B (2018) Over-Expression of GH/GHR in Breast Cancer and Oncosuppressor Role of Somatostatin as a Physiological Inhibitor. Transl Biomed. Vol.9 No.3:151
(testo in italiano)

 Di Bella G, Colori B, Toscano R. Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast. Neuro Endocrinol Lett. 2017;38(6):401-407.
(testo in italiano)

 Di Bella G. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer. Neuro Endocrinol Lett. 2011;32(6):751-762.
(testo in italiano)

 Di Bella G, Mascia F, Ricchi A, Colori B. Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report. Neuro Endocrinol Lett. 2013;34(7):660-668.
(testo in italiano)

 Di Bella G. Complete objective response to biological therapy of plurifocal breast carcinoma. Neuro Endocrinol Lett. 2008;29(6):857-866.
(testo in italiano)